Heart Disease, Ischemic
8
1
2
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
13%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
AB-1002 in Patients With Class III Heart Failure
Prospective WCD Post CABG Registry (CABG Registry)
Low-Carbohydrate and Plant-Based Dietary Effects on Vascular Health
Effectiveness of Music Intervention on Anxiety and Physiological Responses in Critical Ill Patient
Artimes Pro Low Profile Dilatation Catheters for Pre-Dilatation in Patients With Symptomatic Ischemic Heart Disease
Verapamil vs Heparin in Transradial Procedures
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
The Ischemia Modified Albumin In Diagnosing Ischemic New Events